Summary
Six months of dual antiplatelet therapy (DAT; aspirin and clopidogrel) was noninferior to 12 months of DAT after percutaneous coronary intervention with implantation of a drug-eluting stent, according to findings of the EXCELLENT trial.
- Cardiology Clinical Trials
- Interventional Techniques & Devices
- © 2011 MD Conference Express
Tools
Table of contents
Cited By...
- No citing articles found.